| 1991-01 | Assessment of the relationship between plasma nortriptyline concentration and inhibition of salivation : single-dose study | 장인진; 신재국; 신상구, et al |
| 1993-01 | Bioequivalence of generic nortriptyline tablet | 신재국; 차인준; 장인진, et al |
| 1994-01 | Clinical pharmacokinetics of prednisolone and prednisone | 신재국; 윤영란; 차인준, et al |
| 1990-01 | Comparative study of captopril tablets on the bioavailability and the time course of plasma angiotensin-converting enzyme inhibition | 장인진; 이중복; 엄재호, et al |
| 1990-01 | Effect of cimetidine on theophylline disposition and metabolic pathways | 장인진; 이선희; 신재국, et al |
| 2013-11 | Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance | 신광희; 최만호; 임경상, et al |
| 1995-01 | Evaluation of pharmacokinetics and skin irritation of transdermal piroxicam patch(trastR) | 김형기; 임동석; 장인진, et al |
| 2013-08 | GC-MS-based quantitative signatures of cytochrome P450-mediated steroid oxidation induced by rifampicin | 문주연; 강세미; 이정애, et al |
| 2013-03 | Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markers | 김보라; 문주연; 최만호, et al |
| 1990-01 | Kinetics of isoniazid transfer into cerebrospinal fluid in patients with tuberculous meningitis | 신상구; 노재규; 이남수, et al |
| 1995-01 | Pharmacokinetic/pharmacodynamic analysis of metoprolol in dogs | 오동진; 장인진; 이경훈, et al |
| 1990-01 | Pharmacokinetics and pharmacodynamics of intravenous diltiazem in dogs | 박찬웅; 신상구; 신재국, et al |
| 1990-01 | Pharmacokinetics of amitriptyline demethylation : a crossover study with single doses of amitriptyline and nortriptyline | 장인진; 신재국; 신상구, et al |
| 1989-01 | Pharmacokinetics of procainamide and N-acetylprocainamide | 장인진; 신재국; 신상구, et al |
| 1992-09 | Population pharmacokinetics and bayesian feedback method for nortriptyline dosage optimisation | 신상구; 우종인; 장인진, et al |
| 2011-02 | Quantitative and comparative analysis of urinary steroid levels upon treatment of an anti-diabetic drug, CKD-501 using gas chromatography-mass spectrometry | 크리쉬나; 정병화; 장인진, et al |
| 1993-01 | The assessment of the correlation between nortriptyline clearance and metoprolol metabolic ratio | 정원석; 장인진; 이경훈, et al |
| 2010-08 | The study on the urinary steroid metabolic profiling after the treatment of CKD 501 (an anti diabetic drug) in human | 크리쉬나; 정병화; 장인진, et al |
| 2016-09 | Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With
Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction
in Females | 최만호; 신광희; 안리영, et al |
